| 1 | Cancer | 2.21% | |
| 2 | Health | 1.77% | |
| 3 | Treatment | 1.77% | |
| 4 | Clinical | 1.33% | |
| 5 | Patent | 1.33% | |
| 6 | BMC | 1.33% | |
| 7 | Inc | 1.33% | |
| 8 | Trial | 1.33% | |
| 9 | Medical | 0.88% | |
| 10 | Patients | 0.88% | |
| 11 | New | 0.88% | |
| 12 | Tests | 0.88% | |
| 13 | Medicines | 0.88% | |
| 14 | Diversity | 0.88% | |
| 15 | Awareness | 0.88% | |
| 16 | Drug | 0.88% | |
| 17 | Study | 0.88% | |
| 18 | AI | 0.88% | |
| 19 | Parvo | 0.88% | |
| 20 | MS | 0.88% | |
| 21 | Public | 0.88% | |
| 22 | Prostate | 0.88% | |
| 23 | Filing | 0.88% | |
| 24 | Seeking | 0.44% | |
| 25 | Less | 0.44% | |
| 26 | Lions | 0.44% | |
| 27 | Vitiligo | 0.44% | |
| 28 | Shah | 0.44% | |
| 29 | Influenza | 0.44% | |
| 30 | Society | 0.44% | |
| 31 | Gut | 0.44% | |
| 32 | Gain | 0.44% | |
| 33 | Varicella | 0.44% | |
| 34 | Approval | 0.44% | |
| 35 | MyFitnessPal | 0.44% | |
| 36 | Vaccine | 0.44% | |
| 37 | Composition | 0.44% | |
| 38 | Day | 0.44% | |
| 39 | Viral | 0.44% | |
| 40 | Two | 0.44% | |
| 41 | Actually | 0.44% | |
| 42 | Network | 0.44% | |
| 43 | Respiratory | 0.44% | |
| 44 | Unleashes | 0.44% | |
| 45 | Depression | 0.44% | |
| 46 | Poop | 0.44% | |
| 47 | (RSV) | 0.44% | |
| 48 | High | 0.44% | |
| 49 | Vati | 0.44% | |
| 50 | Title | 0.44% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Exploring the role of class IIa HDACs in inflammatory diseases
Drug Target Review
2024-04-23 23:01:33